Researchers have reported a significant development in HIV treatment after a second patient was declared free of the virus following a bone marrow transplant. The individual, known as the London Man, was diagnosed with Hodgkin’s lymphoma in 2012 and underwent the procedure four years later. His donor’s bone marrow carried natural resistance to HIV, a factor that contributed to his remission.
Dr. Ravindra Gupta, a University of London virologist, emphasized that while the patient shows no detectable virus, the term "cure" is not yet confirmed. "This is a case of remission, not definitive eradication," he stated, noting that HIV reservoirs may still exist in the body. Unlike the first documented case in 2007 involving Timothy Ray Brown, this patient experienced fewer side effects due to advancements in medical protocols.
The London Man, who contracted HIV in 2003, has remained off antiretroviral therapy (ART) for 18 months. His case has reignited discussions about potential HIV cures, though experts stress the procedure’s complexity and high cost. In Kenya, where 1.4 million people live with HIV, ART remains the primary treatment. Over 779,000 individuals lack access to any form of antiretroviral care, according to the 2018 Kenya Aids Response Progress Report. The country’s limited availability of bone marrow transplants forces patients to seek treatment abroad, often at prohibitive expenses.
Despite the breakthrough, challenges persist. Kenya records 28,200 HIV/AIDS-related deaths annually, while cancer claims 33,000 lives. HIV-positive individuals face heightened cancer risks due to weakened immunity, underscoring the urgency for accessible, scalable solutions.
